Advanced Cardiac Therapeutics, Inc., is a medical device company focused on developing an innovative temperature-sensing irrigated RF ablation catheter for treatment of cardiac arrhythmias. ACT's TempaSure™ technology features proprietary microwave radiometry technology that can accurately assess volumetric temperature in the heart in real time so that physicians can more precisely control and predict lesion formation for improved clinical outcomes. The Company is developing catheters for a range of ablation procedures, including atrial fibrillation, one of the fastest growing market opportunities in the medical device industry.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/21/14 | undisclosed |
NBGI Ventures | undisclosed | |
| 05/02/17 | $45,000,000 |
Ajax Health Questa Capital Management | undisclosed |
